# The economic burden of loiasis: A comprehensive cost-of-illness analysis of regionally representative, individual-level data from rural Gabon

**Authors:** Cédric Isaac Mbavu, Kerstin Perlik, Tom Stargardt, Selidji Todagbe Agnandji, Olouyomi Scherif Adegnika, Rella Zoleko-Manego, Michael Ramharter, Jan Priebe, David Zhu, David Zhu, David Zhu

PMC · DOI: 10.1371/journal.pone.0340689 · PLOS One · 2026-02-23

## TL;DR

This study quantifies the economic impact of loiasis in rural Gabon, revealing high costs linked to the disease.

## Contribution

The study provides regionally representative cost-of-illness data for loiasis using individual-level data from rural Gabon.

## Key findings

- The average annual cost of loiasis is $39.94 per individual.
- Indirect and non-medical costs dominate the economic burden.
- Treatment costs for loiasis can reach 43% of the average monthly income in the region.

## Abstract

Loiasis is a vector-borne filarial infection endemic to parts of sub-Saharan Africa. It disproportionally affects economically disadvantaged communities in rural, forested regions. To better understand the economic burden of loiasis, we conducted a comprehensive cost-of-illness study in an endemic region of Gabon, with the aim of quantifying the financial costs incurred by individuals infected with the disease from a societal perspective. We conducted a cross-sectional survey in 2023 in rural Gabon. Study participants took part in diagnostic testing for loiasis and were interviewed based on a standardized questionnaire covering a wide range of medical and non-medical costs. Participants reporting eye worm migration or harboring loiasis microfilariae were defined as loiasis positive. Various cost estimates were derived by creating a synthetic control group by means of entropy-balancing and then applying generalized linear models (GLM) for the study region. We show that the average annual costs directly attributable to loiasis amount to 39.94 USD per individual per year. Average cost estimates are primarily driven by indirect costs and direct non-medical costs. We further show that in the rarer cases that individuals seek treatment at formal or informal healthcare providers for loiasis-specific symptoms, costs from the patient’s perspective can be excessively high and amount to about 43 percent of the average monthly per capita income in the study region.

## Linked entities

- **Diseases:** loiasis (MONDO:0016566)

## Full-text entities

- **Genes:** RASSF5 (Ras association domain family member 5) [NCBI Gene 83593] {aka Maxp1, NORE1, NORE1A, NORE1B, RAPL}
- **Diseases:** diseases (MESH:D004194), headaches (MESH:D006261), eye worm (MESH:D004320), Calabar swelling (MESH:D004487), river blindness (MESH:D015827), NTDs (MESH:D058069), lymphatic filariasis (MESH:D004605), organ dysfunctions (MESH:D009102), health problems (MESH:D000076082), renal problems (MESH:D006030), NTD (MESH:D009436), productivity loss (MESH:D007787), onchocerciasis (MESH:D009855), died (MESH:D003643), Infection (MESH:D007239), parasitic infection (MESH:D010272), chronic diseases (MESH:D002908), infectious and chronic diseases (MESH:D003141), impaired cognition (MESH:D003072), Loiasis (MESH:D008118), malaria (MESH:D008288)
- **Chemicals:** methanol (MESH:D000432), water (MESH:D014867), Giemsa (MESH:D001399), PONE-D-25-36336R1 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mansonella perstans (species) [taxon 42231]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12928485/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12928485/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12928485/full.md

---
Source: https://tomesphere.com/paper/PMC12928485